Such extreme reliance has been documented only in oncogene-driven tumors, e.g., KRAS-mutant lung cancer or MYC-amplified brain tumors (Gwynne et al, 2022; Koundinya et al, 2018), and Xu et al extend this concept to NF2-altered mesothelioma. This evidence concerns the gene KRAS and mesothelioma.